Goldman Sachs, the leading foreign brokerage which wields strong influence amongst FIIs and HNI investors, is very bullish about Indian stocks. It has recommended the best stocks which will propel the Nifty to 14100 by the end of 2021
Subscribe to Blog via Email
Join 486 other subscribers
- F&O trader reported verified earning of ₹3.37 Cr in past 12 months from scalping options intradayF&O can be a Gold Mine in skilled hands.@overtrader_ind has reported verified earning of ₹3.37 Cr in the past 12 months from buying options intraday (Scalping). He claims to have converted a paltry ₹3.3 Lakh to ₹3.7 Cr in 1 year which amounts to a mind-boggling ROI of 11,000%
- List of 50 High Dividend yield PSU & Private stocksList of 50 High Dividend yield PSU & Private stocks. Dividend Yield ranges from 2.9% to 6.7%. The dividend yield is computed based on the closing price of 27th September 2024. Only Cos that have consistently paid dividend in the last 3 years are considered Download report
- JB Chemicals is a potent fusion; reiterate BUY with FV of Rs2,255 (23% upside)JB Chemicals offers a healthy cocktail of a robust domestic franchise, niche CMO presence & measured exports strategy, aided by peerless execution. It has handsomely outperformed the IPM in the past decade by ~600 bps & currently ranks 21. TP ₹2255 (+23%)... JB Chemicals is a potent fusion; reiterate BUY with FV of Rs2,255 (23% […]
Recent Posts
- Top Picks Basket for Oct 2024 for Nifty Target of 24600 by Axis Securities
- Dividend Yield Monitor 30 September 2024 by SBI Securities
- JB Chemicals offers a healthy cocktail of a robust domestic franchise, niche CMO presence and measured exports strategy, aided by peerless execution. Buy for target price of ₹2255 (23% upside): Kotak Institutional Equities
- Stylam Industries has industry-leading growth (~2x vs industry) and EBITDA margin (~20%). Buy for target price of ₹2875 (41% upside): HDFC Sec
- Piramal Pharma has chalked out strategic goals for the future. Buy for target price of ₹280 (22% upside): ICICI Direct
Recent Comments